Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2025-03-21 AGM Information
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
1.2 FR - Convening notice AGM April 2025 - FINAL - 20.03.2025.pdf
AGM Information Classification · 99% confidence The document is explicitly titled "CONVOCATION A L'ASSEMBLEE GENERALE DES ACTIONNAIRES" (Notice of General Shareholders' Meeting). It details the agenda for an ordinary general meeting scheduled for April 24, 2025. The agenda items cover the approval of annual accounts for the year ended December 31, 2024, dividend proposals, approval of the remuneration report, approval of the 2025 Remuneration Policy, discharge of directors and the auditor, and appointments/renewals of directors. These elements are characteristic of materials distributed to shareholders in advance of an Annual General Meeting (AGM) to inform their voting decisions. While it touches upon remuneration (DEF 14A topics) and annual accounts (10-K topics), the primary purpose and format are that of a formal notice and agenda for the AGM itself. Therefore, the most appropriate classification is AGM-R (AGM Information).
2025-03-21 French
1.3 NL - Convening notice AGM April 2025 - FINAL - 20.03.2025.pdf
AGM Information Classification · 99% confidence The document is explicitly titled "OPROEPING TOT DE ALGEMENE VERGADERING VAN AANDEELHOUDERS" (Notice of the General Meeting of Shareholders) and details the agenda items for a meeting scheduled for April 24, 2025. The agenda includes voting on the annual accounts, remuneration report, appointment/re-election of directors, and approval of a change of control clause related to financing. These are all core components of materials distributed to shareholders in advance of an Annual General Meeting (AGM). Although it discusses the Annual Report (for FY 2024) and the Remuneration Report, the document itself is the formal notice calling the meeting and outlining the proposals, which aligns perfectly with the definition of AGM Information.
2025-03-21 Dutch
250321 - Acquisition of own shares_ENG.pdf
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from UCB SA/NV regarding the repurchase of its own shares on Euronext Brussels. It details the number of shares repurchased, the dates of the transactions, and the price ranges, which directly aligns with the definition of 'Transaction in Own Shares' (POS).
2025-03-21 English
250321 - Acquisition actions propres_FR.pdf
Transaction in Own Shares Classification · 100% confidence The document is a regulatory announcement from UCB SA regarding the repurchase of its own shares ('Rachat d'actions propres') on Euronext Brussels. It details the number of shares bought, the dates of the transactions, and the average prices paid. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-03-21 French
250321 - Verwerving van eigen aandelen_NL.pdf
Transaction in Own Shares Classification · 100% confidence The document is a regulatory announcement from UCB NV regarding the 'Verwerving van eigen aandelen' (Acquisition of own shares). It details specific share buyback transactions conducted between March 14, 2025, and March 20, 2025, under a share repurchase program. This falls directly under the definition of 'Transaction in Own Shares' (POS).
2025-03-21 Dutch
250314 - Acquisition of own shares_ENG.pdf
Transaction in Own Shares Classification · 100% confidence The document is an official disclosure by UCB SA/NV regarding the repurchase of its own shares under a Share Repurchase Program. It provides specific details on the number of shares repurchased, the dates, and the prices paid. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS).
2025-03-14 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.